After series of denials, his insurer approved doctor-recommended cancer care. It was too late.

Lauren Sausser

For nearly three years, Eric Tennant endured chemotherapy infusions, rounds of radiation, biopsies, and hospitalizations that left him weak and depleted.

“It’s good to be home,” he said after one hospital stay in early June, “yet I’m tired and ready to get on with things.”

In 2023, Tennant, of Bridgeport, West Virginia, was diagnosed with cholangiocarcinoma, a rare cancer of the bile ducts that had spread throughout his body.

None of the initial treatments prescribed by his doctors had eradicated the cancer. But a glimmer of hope came in early 2025, when Tennant was recommended for histotripsy, a relatively new procedure that would use ultrasound waves to target, and potentially destroy, the largest tumor in his body — in his liver.

“My dad was a little nervous because it was something new, but it definitely gave us some hope that he would be around a little bit longer,” said Tennant’s daughter, Amiya.

Read More

Breakthrough gene therapy gives boy hope

CBS 19

A 3-year-old boy born with a rare, devastating genetic disorder has become the first patient in the world to receive a new gene therapy. It is too early to call the therapy a success, but doctors are encouraged by his progress so far.

Watch the video HERE.